SMC and AWMSG HTA submissions, Celgene UK & Ireland

  • Region: UK
  • Date: January 2009

Therapy Area: Multiple myeloma


“Amygdala provided Celgene with much needed flexible external resource and excellent technical support. In particular your contribution to our HTA submissions for Thalidomide Pharmion to both the SMC and AWMSG was first class. Working in partnership with two other agencies you contributed to Celgene‚Äôs first ever positive HTA from the SMC. When Celgene was recently invited by NICE to participate in a multiple technology appraisal of thalidomide and bortezomib for newly diagnosed multiple myeloma, we had no hesitation in inviting you to support us again. I would recommend Amygdala to anyone who is looking for proven, high quality, flexible health economics expertise.”

Associate Director Health Economics

Back to list of testimonials